These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21172032)

  • 21. Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study.
    Rosewich H; Thiele H; Ohlenbusch A; Maschke U; Altmüller J; Frommolt P; Zirn B; Ebinger F; Siemes H; Nürnberg P; Brockmann K; Gärtner J
    Lancet Neurol; 2012 Sep; 11(9):764-73. PubMed ID: 22850527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A de novo mutation in RPL10 causes a rare X-linked ribosomopathy characterized by syndromic intellectual disability and epilepsy: A new case and review of the literature.
    Bourque DK; Hartley T; Nikkel SM; Pohl D; Tétreault M; Kernohan KD; ; Dyment DA
    Eur J Med Genet; 2018 Feb; 61(2):89-93. PubMed ID: 29066376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exome sequencing expands the mechanism of SOX5-associated intellectual disability: A case presentation with review of sox-related disorders.
    Nesbitt A; Bhoj EJ; McDonald Gibson K; Yu Z; Denenberg E; Sarmady M; Tischler T; Cao K; Dubbs H; Zackai EH; Santani A
    Am J Med Genet A; 2015 Nov; 167A(11):2548-54. PubMed ID: 26111154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease.
    Ku CS; Polychronakos C; Tan EK; Naidoo N; Pawitan Y; Roukos DH; Mort M; Cooper DN
    Mol Psychiatry; 2013 Feb; 18(2):141-53. PubMed ID: 22641181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exome sequencing supports a de novo mutational paradigm for schizophrenia.
    Xu B; Roos JL; Dexheimer P; Boone B; Plummer B; Levy S; Gogos JA; Karayiorgou M
    Nat Genet; 2011 Aug; 43(9):864-8. PubMed ID: 21822266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New perspectives for the elucidation of genetic disorders.
    Ropers HH
    Am J Hum Genet; 2007 Aug; 81(2):199-207. PubMed ID: 17668371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole Exome Sequencing Reveals Novel PHEX Splice Site Mutations in Patients with Hypophosphatemic Rickets.
    Ma SL; Vega-Warner V; Gillies C; Sampson MG; Kher V; Sethi SK; Otto EA
    PLoS One; 2015; 10(6):e0130729. PubMed ID: 26107949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into the generation and role of de novo mutations in health and disease.
    Acuna-Hidalgo R; Veltman JA; Hoischen A
    Genome Biol; 2016 Nov; 17(1):241. PubMed ID: 27894357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exons deletion of CNKSR2 gene identified in X-linked syndromic intellectual disability.
    Daoqi M; Guohong C; Yuan W; Zhixiao Y; Kaili X; Shiyue M
    BMC Med Genet; 2020 Apr; 21(1):69. PubMed ID: 32245427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X chromosome exome sequencing reveals a novel ALG13 mutation in a nonsyndromic intellectual disability family with multiple affected male siblings.
    Bissar-Tadmouri N; Donahue WL; Al-Gazali L; Nelson SF; Bayrak-Toydemir P; Kantarci S
    Am J Med Genet A; 2014 Jan; 164A(1):164-9. PubMed ID: 24501762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations.
    Jacquot S; Merienne K; De Cesare D; Pannetier S; Mandel JL; Sassone-Corsi P; Hanauer A
    Am J Hum Genet; 1998 Dec; 63(6):1631-40. PubMed ID: 9837815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders.
    Rabbani B; Mahdieh N; Hosomichi K; Nakaoka H; Inoue I
    J Hum Genet; 2012 Oct; 57(10):621-32. PubMed ID: 22832387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De novo point mutations in patients diagnosed with ataxic cerebral palsy.
    Parolin Schnekenberg R; Perkins EM; Miller JW; Davies WI; D'Adamo MC; Pessia M; Fawcett KA; Sims D; Gillard E; Hudspith K; Skehel P; Williams J; O'Regan M; Jayawant S; Jefferson R; Hughes S; Lustenberger A; Ragoussis J; Jackson M; Tucker SJ; Németh AH
    Brain; 2015 Jul; 138(Pt 7):1817-32. PubMed ID: 25981959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hoyeraal-Hreidarsson syndrome with a DKC1 mutation identified by whole-exome sequencing.
    Lim BC; Yoo SK; Lee S; Shin JY; Hwang H; Chae JH; Hwang YS; Seo JS; Kim JI; Kim KJ
    Gene; 2014 Aug; 546(2):425-9. PubMed ID: 24914498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects.
    Willemsen MH; Vissers LE; Willemsen MA; van Bon BW; Kroes T; de Ligt J; de Vries BB; Schoots J; Lugtenberg D; Hamel BC; van Bokhoven H; Brunner HG; Veltman JA; Kleefstra T
    J Med Genet; 2012 Mar; 49(3):179-83. PubMed ID: 22368300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation.
    Berkel S; Marshall CR; Weiss B; Howe J; Roeth R; Moog U; Endris V; Roberts W; Szatmari P; Pinto D; Bonin M; Riess A; Engels H; Sprengel R; Scherer SW; Rappold GA
    Nat Genet; 2010 Jun; 42(6):489-91. PubMed ID: 20473310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo microdeletions and point mutations affecting SOX2 in three individuals with intellectual disability but without major eye malformations.
    Dennert N; Engels H; Cremer K; Becker J; Wohlleber E; Albrecht B; Ehret JK; Lüdecke HJ; Suri M; Carignani G; Renieri A; Kukuk GM; Wieland T; Andrieux J; Strom TM; Wieczorek D; Dieux-Coëslier A; Zink AM
    Am J Med Genet A; 2017 Feb; 173(2):435-443. PubMed ID: 27862890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High diagnostic yield of syndromic intellectual disability by targeted next-generation sequencing.
    Martínez F; Caro-Llopis A; Roselló M; Oltra S; Mayo S; Monfort S; Orellana C
    J Med Genet; 2017 Feb; 54(2):87-92. PubMed ID: 27620904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. De novo MECP2 frameshift mutation in a boy with moderate mental retardation, obesity and gynaecomastia.
    Kleefstra T; Yntema HG; Oudakker AR; Romein T; Sistermans E; Nillessen W; van Bokhoven H; de Vries BB; Hamel BC
    Clin Genet; 2002 May; 61(5):359-62. PubMed ID: 12081720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SLC1A4 mutations cause a novel disorder of intellectual disability, progressive microcephaly, spasticity and thin corpus callosum.
    Heimer G; Marek-Yagel D; Eyal E; Barel O; Oz Levi D; Hoffmann C; Ruzzo EK; Ganelin-Cohen E; Lancet D; Pras E; Rechavi G; Nissenkorn A; Anikster Y; Goldstein DB; Ben Zeev B
    Clin Genet; 2015 Oct; 88(4):327-35. PubMed ID: 26138499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.